Abstract

BackgroundThe influence of size on the effectiveness of nasobiliary catheters has not yet been studied. We compared biliary drainage effectiveness and procedure-related discomfort and adverse events in 5 French (Fr) and 7 Fr nasobiliary catheters.MethodsWe prospectively studied 100 patients undergoing endoscopic biliary drainage for obstructive jaundice, who were randomly allocated to a 5 Fr or 7 Fr nasobiliary catheter group. As the primary endpoint, the effectiveness was evaluated by the serum total bilirubin decreasing rate and the success rate of jaundice relief. As the secondary endpoint, the degree of discomfort was investigated using a questionnaire survey after catheter removal.ResultsThe bilirubin decrease rate was significantly higher in the 7 Fr catheter group than in the 5 Fr group (53.0 ± 21.4% vs 40.5 ± 29.9%, respectively; P = 0.019). The success rate of jaundice relief tended to be higher in the 7 Fr catheter group, although the difference was not statistically significant (98% vs 88%, respectively; P = 0.056). The questionnaire survey demonstrated that total discomfort was significantly greater in the 7 Fr group (3.9 ± 1.5 vs 3.2 ± 1.4, respectively; P = 0.018). Larger-diameter catheters tended to increase difficulty in eating, although the difference between the groups was not statistically significant.Conclusions7 Fr nasobiliary catheters are recommended for patients requiring rapid and reliable relief of obstructive jaundice. However, because they can cause greater discomfort, 5 Fr nasobiliary catheters are preferred in other settings.Trial registrationOn July 1, 2012; UMIN000008288 (Japan Primary Registries Network).Electronic supplementary materialThe online version of this article (doi:10.1186/1471-230X-14-161) contains supplementary material, which is available to authorized users.

Highlights

  • The influence of size on the effectiveness of nasobiliary catheters has not yet been studied

  • We investigated the effectiveness of bile duct drainage using these catheters as the primary endpoint, and discomfort or other problems related to the nasobiliary catheters as the secondary endpoint

  • The papilla of Vater was manipulated by Endoscopic papillary balloon dilation (EPBD) in 66 cases and by endoscopic sphincterotomy (EST) in 12 cases. 18 cases taking an anticoagulant/ antiplatelet drug and 4 cases showing haemorrhagic diathesis by disseminated intravascular coagulopathy did not undergo papillary manipulation

Read more

Summary

Methods

Study design This study was a prospective, randomized, controlled single-centre trial conducted by multiple endoscopists. The study protocol was approved by the ethics committee of NTT Medical Centre Tokyo and was in accordance with the guidelines of the Declaration of Helsinki for biomedical research involving human subjects This trial was registered on July 1, 2012 in the Japan Primary Registries Network (registration number: UMIN000008288), which is a member of World Health Organization Registry Network. Either a 5 Fr or a 7 Fr nasobiliary catheter was placed into the left or right hepatic duct using a 0.035-inch guide wire (Hydrajagwire 5605; Boston Scientific Corp, Natick, MA) Both sizes of the catheters were 255 cm long, tapered, pigtail tipped, with 9 side holes from the tip and with alpha loop in the duodenal portion (Olympus Medical Systems Corp, Tokyo, Japan). All statistical analyses were performed using PASW statistics version 20 (IBM Corporation, Armonk, NY)

Results
Background
Discussion
Conclusion
11. Pedersen FM
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call